172 related articles for article (PubMed ID: 7688748)
1. The use of serum tumor markers in the management of patients with malignancy.
Markman M
J Cancer Res Clin Oncol; 1993; 119(11):635-6. PubMed ID: 7688748
[No Abstract] [Full Text] [Related]
2. Tumour markers.
Pandha HS; Waxman J
QJM; 1995 Apr; 88(4):233-41. PubMed ID: 7540924
[TBL] [Abstract][Full Text] [Related]
3. The value of cancer antigen-125 as a tumor marker in malignant germ cell tumors of the ovary.
Altaras MM; Goldberg GL; Levin W; Darge L; Bloch B; Smith JA
Gynecol Oncol; 1986 Oct; 25(2):150-9. PubMed ID: 2428701
[TBL] [Abstract][Full Text] [Related]
4. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
Swanson DA
Semin Urol; 1993 May; 11(2):92-8. PubMed ID: 7689741
[No Abstract] [Full Text] [Related]
5. Significance of tumour markers in ovarian cancer.
Bhatavdekar JM; Shah NG; Trivedi SN; Karelia NH
Indian J Cancer; 1987 Mar; 24(1):1-8. PubMed ID: 2448222
[No Abstract] [Full Text] [Related]
6. Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma.
Panza N; Pacilio G; Campanella L; Peluso G; Battista C; Amoriello A; Utech W; Vacca C; Lombardi G
Cancer; 1988 Jan; 61(1):76-83. PubMed ID: 2446734
[TBL] [Abstract][Full Text] [Related]
7. Serum AFP, hCG and CEA in the management of patients with testicular, ovarian and extragonadal germ cell tumors.
Motawy MS; Szymendera JJ; al-Jazzaf H; Behbehani AE; Foudeh MO; Ebraheem AK; Nasralla MY; Ali MA
Int J Biol Markers; 1992; 7(2):80-6. PubMed ID: 1378875
[TBL] [Abstract][Full Text] [Related]
8. Marker (+) CNS germ cell tumors in remission: are surveillance MRI scans necessary?
Martinez S; Khakoo Y; Gilheeney S; Kramer K; Wolden S; Souweidane M; Dunkel IJ
Pediatr Blood Cancer; 2014 May; 61(5):853-4. PubMed ID: 24375894
[TBL] [Abstract][Full Text] [Related]
9. Tumour markers in ovarian cancer.
van Nagell JR
Clin Obstet Gynaecol; 1983 Aug; 10(2):197-212. PubMed ID: 6193919
[No Abstract] [Full Text] [Related]
10. Re: tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors.
Richie JP
J Urol; 2014 Mar; 191(3):659. PubMed ID: 24522037
[No Abstract] [Full Text] [Related]
11. Prognostic factors in metastatic disease.
Droz JP; Kramar A; Rey A
Semin Oncol; 1992 Apr; 19(2):181-9. PubMed ID: 1372760
[No Abstract] [Full Text] [Related]
12. Contributions of immunocytochemistry to the diagnosis and study of ovarian neoplasms.
Kurman RJ; Ganjei P; Nadji M
Int J Gynecol Pathol; 1984; 3(1):3-26. PubMed ID: 6203854
[No Abstract] [Full Text] [Related]
13. Surgical resection of solitary metastases after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers.
Wood DP; Herr HW; Motzer RJ; Reuter V; Sogani PC; Morse MJ; Bosl GJ
Cancer; 1992 Nov; 70(9):2354-7. PubMed ID: 1382832
[TBL] [Abstract][Full Text] [Related]
14. Drug-resistance patterns assessed from tumor marker analysis.
Carl J
J Natl Cancer Inst; 1989 Nov; 81(21):1631-9. PubMed ID: 2477557
[TBL] [Abstract][Full Text] [Related]
15. Tumor markers in the ovarian carcinoma.
Margariti PA; Benedetti Panici P; Villani L; Di Roberto P; Maiorca A; Sacco F; Bompiani A
Eur J Gynaecol Oncol; 1980 May; 1(2):77-9. PubMed ID: 6174341
[No Abstract] [Full Text] [Related]
16. A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours.
Murray MJ; Bell E; Raby KL; Rijlaarsdam MA; Gillis AJ; Looijenga LH; Brown H; Destenaves B; Nicholson JC; Coleman N
Br J Cancer; 2016 Jan; 114(2):151-62. PubMed ID: 26671749
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of five tumor markers (AFP, CEA, hCG, hPL and SP1) in monitoring therapy and follow-up of patients with testicular germ cell tumors.
Szymendera JJ; Zborzil J; Sikorowa L; Leńko J; Kamińska JA; Gadek A
Oncology; 1983; 40(1):1-10. PubMed ID: 6185897
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and immunologic diagnosis of cancer. Germ cell tumors.
Schwartz MK
Tumour Biol; 1987; 8(2-3):106-8. PubMed ID: 2452467
[No Abstract] [Full Text] [Related]
19. The role of tumor markers in gynecologic oncology.
Olt G; Berchuck A; Bast RC
Obstet Gynecol Surv; 1990 Sep; 45(9):570-7. PubMed ID: 1697940
[TBL] [Abstract][Full Text] [Related]
20. [Tumor markers in gynecology].
Alekseeva ML; Fanchenko ND; Novikov EA; Margiani FR
Akush Ginekol (Mosk); 1995; (5):35-7. PubMed ID: 8579206
[No Abstract] [Full Text] [Related]
[Next] [New Search]
